Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-007020
Filing Date
2022-02-18
Accepted
2022-02-18 16:16:30
Documents
1
Period of Report
2022-02-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3838
  Complete submission text file 0000899243-22-007020.txt   5151
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 680 SOUTH FOURTH STREET LOUISVILLE KY 40202
Business Address
DIAZ PAUL J (Reporting) CIK: 0001194247 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 22652966